| BRE005 |
Breast |
A Phase 3 Open-Label, Randomized, Study of a Drug versus Treatment of Physician’s Choice in Patients with Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated |
NCT02915744 |
| BRE006 |
Breast |
A phase 3, Randomized, Open-Label Trial to Evaluate Efficacy and Safety of a Drug with Endocrine Therapy as Adjuvant Treatment in Patients with Hormone Receptor-Positive, HER2-Negative, Early Breast Cancer |
NCT03701334 |
| #ENDO001 |
Endometrial |
A Phase 1a/1b Study of an Antibody, in Patients with Advanced Solid Tumors |
NCT03514121 |
| ENDO002 |
Endometrial |
A Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety of a drug in Combination with Another Drug Versus Treatment of Physician’s Choice in Participants with Advanced Endometrial Cancer |
NCT03884101 |
| GAS001 |
Gastric |
A Phase 3 Randomized, Double-Blind, Controlled Study Evaluating a drug in patients with Previously Untreated Advanced Gastric and Gastroesophageal Cancer |
NCT03694522 |
| LUN002 |
Lung NSCLC |
A Randomized, Double-Blind, Phase 3 Study of chemptherapy with or without a drug in EGFR-mutated Tumors in Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) |
NCT03515837 |
| LYM005 |
Lymphoma |
A Multi-Center, Open label, Dose Escalation, Phase I/Ib Study to Evaluate the Safety and Efficacy of a Drug in Patients with Relapsed or Refractory Lymphomas |
NCT03119647 |
| LYM003 |
Lymphoma |
A Phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of a Drug in Combination with Another Drug in patients with relapsed indolent B-cell non-Hodgkin’s lymphoma (iNHL). |
NCT02367040 |
| MDS001 |
MDS Low Risk |
A Phase3,Open-Label,Randomized Study to Compare the Efficiancy and Safety of a Drug Versus another Drug for the Treatment of Anemia in Very Low, Low or Intermediate Risk MDS who Require Red Blood Cell Transfusions |
NCT03682536 |
| MM001 |
Multiple Myeloma |
Multicenter Phase 2 Study to Evaluate Subcutaneous Drug in Combination with Standard Multiple Myeloma Treatment Regimens |
NCT03412565 |
| #OVA004 |
Ovarian |
A Phase 1a/1b Study of an Antibody, in Patients with preiously treated Ovarian Cancer |
NCT03514121 |
| OVA005 |
Ovarian |
A Randomized, Double-Blind, Phase 3 Study Comaparison of Platinum-Based Therapy with Two Drugs Versus Standard of Care Platinum-Based Therapy as First-Line Treatment of Stage III of IV Nonmucinous Epithelial Ovarian Cancer |
NCT03602859 |
| PRO002 |
Prostate |
A Phase 1b-2 Study of a Drug in Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer |
NCT03431350 |
| REN004 |
Renal |
A Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a drug as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy |
NCT03142334 |
